Digital Biomarkers Market Insights, Growth & Opportunity Outlook, 2024-2035: Quibim’s Qp-brain Leads Neurodegenerative Disorder Detection, Alivecor’s Kardiamobile Card Cleared For Rapid Ecg Diagnosis

The global digital biomarkers market is projected to reach USD 35.8 billion by 2035, growing at a CAGR of 18.5% from 2024. The market is driven by the rising prominence of telemedicine and the implementation of continuous monitoring systems, which have proven to reduce adverse events and hospital re-admissions. Digital biomarkers and therapeutics are a part of the broader digital health market, and are expected to play a crucial role in the timely treatment of patients, especially the aging population.